Neuroimmunology Update 2025: AQP4+ NMOSD Treatment Landscape
Dr. Justin Abbatemarco discusses updates around treatments in AQP4+ NMOSD. Show references
Read the full articleYou might also wanna read
An Exploratory Study of Obinutuzumab β in the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Conditions : Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP); Obinutuzumab β Interventions : Drug: Obinutuzumab β Sponsors
clinicaltrials.gov·7d ago
Advances in Brain-on-a-Chip and BBB-on-a-Chip Models for Neurodegenerative Disease Research
Brain-on-a-chip is a microphysiologic platform that comprises cultured brain cells to understand brain disease pathogenesis and treatment. T
journals.sagepub.com·22d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.